Today Challenge is the only independently owned, exclusively pharmaceutical printer to accomplish "critical mass". This combination of laser-like focus and wide market reach has fueled our dramatic growth and has helped us become the de facto choice of pharmaceutical manufacturers.
Our profit reinvestment strategy has enabled us to deliver value to our customers through the acquisition of unique technologies. In turn, our market success provides us with the financial stability required to sustain our independent path.
Through the formation of an Urgent Response Team (URT), we are able to complete new product launches for our customers within 24 hours or less.
Our responsiveness to customers' needs is enhanced through the use of a secure, electronic network, which connects our facilities and delivers valuable feedback from the manufacturing floor on a real-time basis.